SAMSUNG PHARM. Co., LTD. Market Cap

SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 150.69 billion as of February 21, 2025. Its market cap has increased by 5.65% in one year.

Market Cap

150.69B

Enterprise Value

n/a

Revenue

44.65B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,625.00

Market Cap Chart

Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 150.69B, an increase of 742.54%. That is a compound annual growth rate of 7.49%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	150.69B	4.10%
Dec 30, 2024	144.76B	-0.84%
Dec 28, 2023	145.99B	-18.99%
Dec 29, 2022	180.22B	-45.48%
Dec 30, 2021	330.57B	-11.17%
Dec 30, 2020	372.12B	50.47%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	83.63T
Celltrion	38.25T
SK Biopharmaceuticals	9,773.49B
Yuhan	9,276.18B
SK bioscience	3,729.33B
Hanmi Pharm.	3,328.56B
Hanall Biopharma	1,995.45B
Hanmi Science	1,946.77B

Market Cap Rankings